Sign in
4

Changes in Ownership

OptimizeRx Corp Filed Acc 0001628280-25-041110

CFO/COO acquired 15,625 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I In the form
Stelmakh Edward CFO/COO 2025-08-21 Grant or award +15,625 110,764 D
Derivatives
Stelmakh Edward CFO/COO 2025-08-21 Grant or award · Stock Option +35,156 35,156 D
Loading xslF345X05/wk-form4_1756149661.xml…